Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury
Open Access
- 21 February 2024
- journal article
- review article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 16 (1) , 1-17
Abstract
Spinal cord injury (SCI) is a severe neurological disorder that causes neurological impairment and disability. Neural stem/progenitor cells (NS/PCs) derived from induced pluripotent stem cells (iPSCs) represent a promising cell therapy strategy for spinal cord regeneration and repair. However, iPSC-derived NS/PCs face many challenges and issues in SCI therapy; one of the most significant challenges is epigenetic regulation and that factors that influence this mechanism. Epigenetics refers to the regulation of gene expression and function by DNA methylation, histone modification, and chromatin structure without changing the DNA sequence. Previous research has shown that epigenetics plays a crucial role in the generation, differentiation, and transplantation of iPSCs, and can influence the quality, safety, and outcome of transplanted cells. In this study, we review the effects of epigenetic regulation and various influencing factors on the role of iPSC-derived NS/PCs in SCI therapy at multiple levels, including epigenetic reprogramming, regulation, and the adaptation of iPSCs during generation, differentiation, and transplantation, as well as the impact of other therapeutic tools (e.g., drugs, electrical stimulation, and scaffolds) on the epigenetic status of transplanted cells. We summarize our main findings and insights in this field and identify future challenges and directions that need to be addressed and explored.Keywords
Funding Information
- National Natural Science Foundation of China (81371957)
This publication has 165 references indexed in Scilit:
- Medial ganglionic eminence–like cells derived from human embryonic stem cells correct learning and memory deficitsNature Biotechnology, 2013
- Generating pluripotent stem cells: Differential epigenetic changes during cellular reprogrammingFEBS Letters, 2012
- Constitutive heterochromatin reorganization during somatic cell reprogrammingThe EMBO Journal, 2011
- Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cellsNature, 2011
- Histone H3K27ac separates active from poised enhancers and predicts developmental stateProceedings of the National Academy of Sciences, 2010
- Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cellsNature Biotechnology, 2010
- Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injuryProceedings of the National Academy of Sciences, 2010
- Epigenetic regulation of oligodendrocyte identityTrends in Neurosciences, 2010
- Combinatorial patterns of histone acetylations and methylations in the human genomeNature Genetics, 2008
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007